Johannes Routila
MD, PhD
johannes.routila@utu.fi |
head and neck cancer; radioresistance; biomarkers; audiology; vestibulology; neuro-otology
Dissertation focused on the use of biomarkers in head and neck cancer therapy selection with special focus on radio- and chemoradiosensitivity associated stemness-related biomarkers.
In addition, I have research interests covering the fields of audiology and neuro-otology.
2 of 2
- Diagnoosin muodostuminen mahdollisuuksien pelitilassa (2021)
- Sosiaalilääketieteellinen Aikakauslehti
- Evaluation of prognostic biomarkers in a population-validated Finnish HNSCC patient cohort (2021)
- European Archives of Oto-Rhino-Laryngology
- Tracheobronchial stents in patients with malignant airway disease: Finnish tertiary care experience (2021)
- Interactive Cardiovascular and Thoracic Surgery
- Hepatocyte Growth Factor Receptor overexpression predicts reduced survival but its targeting is not effective in unselected HNSCC patients (2020)
- Head and Neck
- Tutkimusasetelman jälkikäteinen arviointi on asianmukaisuuden arviointia (2020)
- Lääkärilehti
- Magneettikuva osoittaa kalkkiutumat (2019)
- Lääkärilehti
- Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma (2016)
- Journal of Oral Pathology and Medicine
- Potential Role for Inhibition of Protein Phosphatase 2A Tumor Suppressor in Salivary Gland Malignancies (2016)
- Genes, Chromosomes and Cancer
UTU Research Portal